Advertisement

Topics

Wetherby Asset Management Inc. Acquires 320 Shares of Regeneron Pharmaceuticals, Inc.

03:57 EDT 12 Aug 2017 | Topix

Wetherby Asset Management Inc. raised its stake in shares of Regeneron Pharmaceuticals, Inc. by 25.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,580 shares of the biopharmaceutical company's stock after buying an additional 320 shares during the period.

Original Article: Wetherby Asset Management Inc. Acquires 320 Shares of Regeneron Pharmaceuticals, Inc.

NEXT ARTICLE

More From BioPortfolio on "Wetherby Asset Management Inc. Acquires 320 Shares of Regeneron Pharmaceuticals, Inc."

Quick Search
Advertisement
 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...